Evofem Biosciences, Inc.
EVFM
$0.01
$0.002.67%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 144.00K | 1.62M | 131.00K | 127.00K | 125.00K |
| Total Receivables | 2.69M | 748.00K | 12.86M | 4.44M | 4.93M |
| Inventory | 2.16M | 1.89M | 1.13M | 1.68M | 1.91M |
| Prepaid Expenses | 389.00K | 161.00K | 436.00K | 650.00K | 868.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 709.00K | 1.64M | 731.00K | 1.02M | 1.14M |
| Total Current Assets | 6.08M | 6.06M | 15.28M | 7.92M | 8.97M |
|
|
|||||
| Total Current Assets | 6.08M | 6.06M | 15.28M | 7.92M | 8.97M |
| Net Property, Plant & Equipment | 530.00K | 566.00K | 600.00K | 615.00K | 638.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 869.00K | 778.00K | 4.35M | 5.24M | 4.74M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 41.00K | 42.00K | 42.00K | 36.00K | 36.00K |
| Total Assets | 7.52M | 7.44M | 20.27M | 13.81M | 14.38M |
|
|
|||||
| Total Accounts Payable | 12.15M | 12.00M | 13.15M | 11.62M | 12.29M |
| Total Accrued Expenses | 3.75M | 2.70M | 3.88M | 4.97M | 6.58M |
| Short-term Debt | 20.20M | 18.92M | 21.60M | 19.78M | 47.10M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 34.12M | 33.51M | 32.90M | 32.29M | 124.00K |
| Total Finance Division Other Current Liabilities | 18.40M | 11.62M | 13.29M | 9.52M | 7.81M |
| Total Other Current Liabilities | 18.40M | 11.62M | 13.29M | 9.52M | 7.81M |
| Total Current Liabilities | 88.62M | 78.75M | 84.82M | 78.19M | 73.89M |
|
|
|||||
| Total Current Liabilities | 88.62M | 78.75M | 84.82M | 78.19M | 73.89M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 20.20M | 18.92M | 21.60M | 19.78M | 47.10M |
| Capital Leases | 4.00K | 27.00K | 54.00K | 72.00K | 89.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.39M | 1.38M | 4.84M | 5.72M | 5.23M |
| Total Liabilities | 90.01M | 80.15M | 89.71M | 83.98M | 79.21M |
|
|
|||||
| Common Stock & APIC | 831.89M | 831.89M | 831.87M | 831.83M | 831.44M |
| Retained Earnings | -914.02M | -902.88M | -897.39M | -900.18M | -898.50M |
| Treasury Stock & Other | -5.39M | -6.64M | -8.82M | -6.72M | -2.56M |
| Total Common Equity | -87.52M | -77.63M | -74.34M | -75.07M | -69.62M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 5.03M | 4.92M | 4.90M | 4.90M | 4.79M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 5.03M | 4.92M | 4.90M | 4.90M | 4.79M |
|
|
|||||
| Total Common Equity | -87.52M | -77.63M | -74.34M | -75.07M | -69.62M |
| Total Preferred Equity | 5.03M | 4.92M | 4.90M | 4.90M | 4.79M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -82.49M | -72.71M | -69.44M | -70.17M | -64.83M |
|
|
|||||